Malaysia’s medical technology (MedTech) sector is making strong strides, contributing RM1.8 billion to GDP, generating over 130,000 high-skilled jobs, and recording 31% export growth to RM37 billion in 2024, supported by RM20 billion in investments from 2021–2024. [1] MedTech has long supported healthcare delivery, but COVID-19 made its role undeniable.
In Malaysia, both public and private providers have accelerated the use of digital health tools, from AI-enabled clinical support, and connected medical devices to sustain care continuity. This period also exposed a deeper, system-level reality: technology adoption alone is not enough. Progress remains uneven across facilities, with gaps in digital readiness, data interoperability, and workforce capability limiting the full potential of these innovations. As the country moves toward a more integrated, technology-enabled health ecosystem, stronger public–private partnerships will be key to unlock the next phase of MedTech-driven resilience and innovation, strengthening public–private collaboration will be critical for building a more resilient and integrated health ecosystem.
Our Innovate to Integrate thought leadership article series takes a closer look at the factors shaping MedTech adoption across Southeast Asia, reframing the region’s challenges and opportunities through the lens of the 3As:
3. Accessibility and affordability
Instead of treating these as separate steps, the series highlights how they function as a unified framework for meaningful MedTech deployment. Drawing on case studies from across Southeast Asia, the series explores how hospitals, policymakers, and MedTech companies can bridge capability gaps, align incentives, and build the digital infrastructure required to move from isolated pilots to system-wide transformation. Together, these insights outline a clear pathway for sustainable MedTech integration and a digitally enabled, patient-centered healthcare future in Malaysia and across the region.
[1] Bernama, Malaysia's medical device exports surge 31 pct to rm37 bln in 2024 – Health Minister, 15 October 2025.
